Search
Tuesday 18 August 2015
  • :
  • :
Latest Update

Friday’s Trade News Alert on: Royal Dutch Shell (NYSE:RDS.A), Noble Energy, (NYSE:NBL), Apache (NYSE:APA), Esperion Therapeutics (NASDAQ:ESPR)

On Friday, Royal Dutch Shell plc (ADR) (NYSE:RDS.A)’s shares declined -2.58% to $54.38.

Royal Dutch Shell plc (RDS-A) declared that its recommended combination with BG Group plc (“BG”) has received unconditional merger clearance from the Brazilian competition authority (CADE), satisfying the first of the pre-conditions to the combination. Other pre-conditions comprise merger clearances in Australia, China and Europe.

Following comments made in June, when the recommended combination cleared its first antitrust hurdle in the United States, van Beurden also recently re-confirmed the filing process is well underway in the remaining pre-conditional and other jurisdictions, and the recommended combination remains on track to complete in early 2016. The pre-conditions and conditions to the combination are set out in the 8 April deal declarement.

Royal Dutch Shell plc operates as an independent oil and gas company worldwide. It operates through Upstream and Downstream segments. The company explores for and extracts crude oil, natural gas, and natural gas liquids. It also converts natural gas to liquids to provide fuels and other products; markets and trades natural gas; extracts bitumen from mined oil sands and converts it to synthetic crude oil; and generates electricity from wind energy.

Noble Energy, Inc. (NYSE:NBL)’s shares dropped -3.62% to $35.37.

Noble Energy, Inc. ( NBL) declared that its Board of Directors has declared a quarterly cash dividend of 18 cents per common share payable on August 17, 2015 to the shareholders of record at the close of business on August 3, 2015.

Noble Energy, Inc., an independent energy company, engages in the acquisition, exploration, and production of crude oil, natural gas, and natural gas liquids worldwide. Its principal projects are located in onshore DJ Basin and Marcellus Shale, the United States; the deepwater Gulf of Mexico; offshore West Africa; and offshore Eastern Mediterranean.

At the end of Friday’s trade, Apache Corporation (NYSE:APA)‘s shares dipped -4.75% to $45.10.

Apache Corporation ( APA) will release its second-quarter 2015 results at 7 a.m. Central time on Thursday, Aug. 6, 2015, followed by a conference call to talk about its results at 1 p.m. Central time.

Apache Corporation, an independent energy company, explores, develops, and produces natural gas, crude oil, and natural gas liquids. It operates onshore and offshore assets primarily in the Permian Basin, the Anadarko basin in western Oklahoma, and the Texas Panhandle, Gulf Coast areas of the United States, in addition to in Western Canada.

Esperion Therapeutics Inc (NASDAQ:ESPR), ended its Friday’s trading session with -20.71% loss, and closed at $75.91.

Esperion Therapeutics, Inc. (ESPR), an emerging pharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-cholesterol) lowering therapies for the treatment of hypercholesterolemia and other cardiometabolic risk markers, recently declared that it will host its second annual analyst and investor day event and webcast for institutional investors and research analysts on Thursday, July 30 at 8:30 a.m. Eastern Time.

Esperion Therapeutics, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of oral and low-density lipoprotein cholesterol lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers. Its products comprise ETC-1002, an oral molecule therapy that is in Phase 2b clinical trials to treat patients with hypercholesterolemia, in addition to to lower levels of LDL-cholesterol, and avoid various side effects associated with LDL-cholesterol lowering therapies.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *